Skip to main content
. Author manuscript; available in PMC: 2024 Jul 30.
Published in final edited form as: Cancer Epidemiol. 2022 Feb 1;77:102117. doi: 10.1016/j.canep.2022.102117

Fig. 3.

Fig. 3.

Serial serum samples analysis showing IgA and IgG antibody progression for one patient with Epstein-Barr virus small RNA 1 in situ hybridization (EBER-ISH) positive tumor sample. The progression shows prediagnostic IgA and IgG antibody levels in a single patient over time. Blood was drawn 31, 24, 23, 20, 19 and 18 years prior to diagnosis. The dashed line indicates the lower limit of quantification of 30 MFI.